N
LH icon

Nuveen’s Labcorp LH Stock Holding History

Nuveen’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.3M Buy
244,836
+39,248
+19% +$10.6M 0.02% 536
2025
Q4 		$51.6M Sell
205,588
-19,468
-9% -$5.17M 0.01% 624
2025
Q3 		$64.6M Sell
225,056
-1,943
-0.9% -$521K 0.02% 527
2025
Q2 		$59.6M Buy
226,999
+19,933
+10% +$4.85M 0.02% 542
2025
Q1 		$48.2M Sell
207,066
-10,647
-5% -$2.58M 0.01% 633
2024
Q4 		$49.9M Sell
217,713
-527,411
-71% -$121M 0.01% 652
2024
Q3 		$167M Sell
745,124
-11,707
-2% -$2.57M 0.05% 313
2024
Q2 		$154M Sell
756,831
-53,064
-7% -$10.8M 0.05% 307
2024
Q1 		$177M Sell
809,895
-110,634
-12% -$24.4M 0.05% 282
2023
Q4 		$209M Buy
920,529
+18,609
+2% +$3.91M 0.07% 236
2023
Q3 		$181M Sell
901,920
-164,342
-15% -$34.7M 0.06% 239
2023
Q2 		$221M Buy
1,066,262
+641,910
+151% +$125M 0.08% 207
2023
Q1 		$83.6M Buy
424,352
+45,369
+12% +$9.34M 0.03% 406
2022
Q4 		$76.7M Sell
378,983
-20,083
-5% -$3.93M 0.03% 420
2022
Q3 		$70.2M Sell
399,066
-4,813
-1% -$985K 0.03% 430
2022
Q2 		$81.3M Sell
403,879
-7,217
-2% -$1.54M 0.03% 407
2022
Q1 		$97.7M Sell
411,096
-58,541
-12% -$13.8M 0.03% 424
2021
Q4 		$127M Sell
469,637
-21,831
-4% -$5.4M 0.04% 383
2021
Q3 		$119M Sell
491,468
-15,627
-3% -$3.94M 0.04% 392
2021
Q2 		$120M Sell
507,095
-18,374
-3% -$4.19M 0.04% 422
2021
Q1 		$115M Sell
525,469
-27,298
-5% -$5.48M 0.04% 417
2020
Q4 		$96.7M Buy
552,767
+25,366
+5% +$4.38M 0.03% 434
2020
Q3 		$85.3M Sell
527,401
-40,874
-7% -$6.48M 0.03% 412
2020
Q2 		$81.1M Sell
568,275
-40,477
-7% -$5.6M 0.03% 424
2020
Q1 		$66.1M Sell
608,752
-343,488
-36% -$49.5M 0.03% 410
2019
Q4 		$138M Sell
952,240
-209,254
-18% -$30.2M 0.05% 325
2019
Q3 		$168M Sell
1,161,494
-28,591
-2% -$4.17M 0.07% 270
2019
Q2 		$177M Buy
1,190,085
+1,178,790
+10,436% +$164M 0.07% 285
2019
Q1 		$1.49M Sell
11,295
-240
-2% -$29.6K 0.01% 679
2018
Q4 		$1.25M Buy
11,535
+59
+0.5% +$7.9K 0.01% 680
2018
Q3 		$1.71M Sell
11,476
-8
-0.1% -$1.22K 0.01% 667
2018
Q2 		$1.77M Buy
11,484
+622
+6% +$93.9K 0.01% 630
2018
Q1 		$1.51M Buy
10,862
+78
+0.7% +$11.5K 0.01% 659
2017
Q4 		$1.48M Sell
10,784
-6
-0.1% -$793 0.01% 657
2017
Q3 		$1.4M Sell
10,790
-1,287
-11% -$172K 0.01% 685
2017
Q2 		$1.6M Sell
12,077
-3,320
-22% -$407K 0.01% 652
2017
Q1 		$1.9M Sell
15,397
-10,536
-41% -$1.25M 0.01% 718
2016
Q4 		$2.86M Buy
25,933
+9,426
+57% +$1.05M 0.01% 783
2016
Q3 		$1.95M Buy
16,507
+119
+0.7% +$14K 0.01% 800
2016
Q2 		$1.83M Buy
16,388
+528
+3% +$56.8K 0.01% 782
2016
Q1 		$1.6K Buy
15,860
+8,971
+130% +$860K 0.01% 840
2015
Q4 		$732 Hold
6,889
– – ﹤0.01% 1180
2015
Q3 		$642 Hold
6,889
– – ﹤0.01% 1251
2015
Q2 		$717 Hold
6,889
– – ﹤0.01% 1276
2015
Q1 		$746K Sell
6,889
-6,790
-50% -$698K ﹤0.01% 1265
2014
Q4 		$1.27M Buy
13,679
+7,084
+107% +$626K 0.01% 1077
2014
Q3 		$577K Hold
6,595
– – ﹤0.01% 1317
2014
Q2 		$580K Sell
6,595
-659
-9% -$57.1K ﹤0.01% 1332
2014
Q1 		$612K Sell
7,254
-264
-4% -$21.1K ﹤0.01% 1304
2013
Q4 		$590K Buy
+7,518
New +$641K ﹤0.01% 1277
2013
Q3 		– Sell
-8,009
Closed -$689K – 1528
2013
Q2 		$689K Buy
+8,009
New +$665K ﹤0.01% 1193

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen's LH Position: Q1 2026 in Review

Nuveen increased its Labcorp (LH) stake by 19% in Q1 2026, buying an estimated $10.6M and bringing the position to 244,836 shares worth $65.3M. The position accounts for 0.02% of the portfolio, ranked #536.

Nuveen first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $221M in Q2 2023. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Nuveen held 244,836 shares of Labcorp worth $65.3M as of Q1 2026.
  • Nuveen bought 39,248 Labcorp shares in Q1 2026, an estimated $10.6M.
  • Labcorp made up 0.02% of Nuveen's portfolio in Q1 2026, its #536 holding.
  • Nuveen first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
  • Nuveen's Labcorp position peaked at $221M in Q2 2023.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.